Advertisement

Neos Therapeutics, Inc. NEOS

Set alert

Price alert · NEOS

All alert types

No live quote for NEOS yet.

Open
1.16
Prev close
1.18
Mkt cap
57.22M
Vol
15.01M
Avg vol
7.10M
P/E
0.00
Div yield
0.00%
More statistics
Low
1.06
High
1.18
Forward P/E
-19.17
Beta
0.00
Dividend
0.00
Ex-div date
50-d avg
0.9922
200-d avg
0.733477
1y target
1.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NEOS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Other Income → Expenses: $12.00KAdzenys Product → Revenue: $6.18MExpenses → Selling, General & Admin: $9.02MExpenses → Research & Development: $1.31MExpenses → Interest Expense: $2.00MExpenses → Income Tax: $2.00KGross Profit → Expenses: $7.42MRevenue → Gross Profit: $7.42MRevenue → Cost of Revenue: $5.12MCotempla Xr Odt → Revenue: $5.60MNet Loss → Expenses: $4.91MGeneric Tussionex Product → Revenue: $660.00KAdzenys Er → Revenue: $102.00KOther Income$12.00KGross Profit$7.42MNet Loss$4.91MCost of Revenue$5.12MExpenses$12.34MSelling, General & Admin$9.02MResearch & Development$1.31MInterest Expense$2.00MIncome Tax$2.00KRevenue$12.54MAdzenys Product$6.18MCotempla Xr Odt$5.60MGeneric Tussionex Product$660.00KAdzenys Er$102.00K

Period ending Sep 30, 2020 · select a line to chart its history

Income statement

NEOS quarterly income statement
12.54M
12.54M
5.12M
7.42M
10.33M
1.31M
9.02M
-2.92M
2.00M
2.00K
-4.91M
-4.91M
-4.91M
-4.91M
-0.10
-0.10
-0.10
-2.90M
-2.90M
49.76M
49.76M

Balance sheet

NEOS quarterly balance sheet
12.74M
12.74M
20.39M
44.01M
8.48M
64.58M
27.48M
43.95M
67.16M
16.46M
85.14M
-352.25M
-20.55M
-20.55M
20.57M
43.95M
11.07M
8.44M
17.98M
8.44M

Cash flow

NEOS quarterly cash flow
1.10M
2.16M
65.00K
21.00K
2.16M
21.00K
-2.11M
532.00K
Advertisement